AT330122B - PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS - Google Patents

PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS

Info

Publication number
AT330122B
AT330122B AT1111571A AT1111571A AT330122B AT 330122 B AT330122 B AT 330122B AT 1111571 A AT1111571 A AT 1111571A AT 1111571 A AT1111571 A AT 1111571A AT 330122 B AT330122 B AT 330122B
Authority
AT
Austria
Prior art keywords
hydrolasis
glycoside
digestive
producing new
new inhibitors
Prior art date
Application number
AT1111571A
Other languages
German (de)
Other versions
ATA1111571A (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to AT610074A priority Critical patent/AT330126B/en
Publication of ATA1111571A publication Critical patent/ATA1111571A/en
Application granted granted Critical
Publication of AT330122B publication Critical patent/AT330122B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
AT1111571A 1970-12-28 1971-12-24 PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS AT330122B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT610074A AT330126B (en) 1970-12-28 1974-07-24 PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (en) 1970-12-28 1970-12-28 Actinomycete glycoside hydrolase inhibitors

Publications (2)

Publication Number Publication Date
ATA1111571A ATA1111571A (en) 1975-09-15
AT330122B true AT330122B (en) 1976-06-10

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1111571A AT330122B (en) 1970-12-28 1971-12-24 PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS

Country Status (28)

Country Link
US (1) US3876766A (en)
JP (3) JPS5734996B1 (en)
KR (1) KR780000248B1 (en)
AR (1) AR193370A1 (en)
AT (1) AT330122B (en)
AU (1) AU461521B2 (en)
BE (1) BE777387A (en)
BG (3) BG25654A3 (en)
CA (1) CA979833A (en)
CH (1) CH594051A5 (en)
CS (1) CS167961B2 (en)
DD (1) DD99395A5 (en)
DE (1) DE2064092C2 (en)
DK (1) DK139533C (en)
ES (1) ES398358A1 (en)
FI (1) FI49774C (en)
FR (1) FR2120073B1 (en)
GB (1) GB1374751A (en)
IE (1) IE35920B1 (en)
IL (1) IL38441A (en)
LU (1) LU64319A1 (en)
NL (1) NL175199C (en)
NO (1) NO135873C (en)
PL (1) PL82900B1 (en)
RO (3) RO63065A (en)
SE (1) SE398357B (en)
SU (1) SU454750A3 (en)
ZA (1) ZA718677B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209833C3 (en) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Manufacture of an amylase inhibitor
DE2209832C3 (en) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Manufacture of saccharase inhibitors
DE2209834C3 (en) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Manufacture of saccharase inhibitors
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (en) * 1976-01-22 1977-08-19 Rhone Poulenc Ind NEW GLYCO-HYDROLASE INHIBITOR AND ITS PREPARATION BY CULTURE OF A STREPTOMYCES
DE2658563A1 (en) * 1976-12-23 1978-06-29 Bayer Ag Glucoside hydrolase inhibitors prodn. from bacteria - esp. Bacillus species useful, e.g., for increasing meat yields and feed efficiency
DE2701890C2 (en) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Streptomycete peptic glycoside hydrolase inhibitor and its use
DE2719912C3 (en) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Process for the isolation of 0- | 4,6-dideoxy-4- [JJl SO, 4,6 / 5) -4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a - D-glucopyranosyl} - (I right arrow 4) -0- a D-glucopyranosyl- (l right arrow 4) -D-glucopyranose from culture broths
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (en) * 1986-01-07 1987-07-16 シャープ株式会社 electronic automatic flasher
ATE89563T1 (en) * 1986-08-13 1993-06-15 Hoechst Ag OXIRAN-PSEUDOOLIGOSACCHARIDES, PROCESSES FOR THEIR PRODUCTION, THEIR USE AND PHARMACEUTICAL PREPARATIONS.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (en) * 1995-03-02 1996-10-31 Bayer Ag Acarbose biosynthesis genes from Actinoplanes sp., Process for their isolation and their use
EP0796915A3 (en) * 1996-03-22 1999-04-14 Bayer Ag Process for the preparation and use of acarviosyl-transferase in the conversion of ascarbose-homologous in acarbose and in the preparation of acarbose-homologous
DE19637591A1 (en) * 1996-09-13 1998-03-19 Bayer Ag Osmocontrolled fermentation process for the production of acarbose
KR100383435B1 (en) 1999-10-28 2003-05-12 주식회사종근당 A process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
IN2014CN04155A (en) 2011-12-08 2015-07-17 Bayer Ip Gmbh
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
KR20220081991A (en) 2019-10-16 2022-06-16 바이엘 악티엔게젤샤프트 Method for improved formation of acarbose
CA3172525A1 (en) 2020-03-23 2021-09-30 Tanya Jeradechachai Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
SU454750A3 (en) 1974-12-25
AU461521B2 (en) 1975-05-29
RO61400A (en) 1977-01-15
JPS57150395A (en) 1982-09-17
LU64319A1 (en) 1972-06-13
AU3721471A (en) 1973-09-27
NL175199B (en) 1984-05-01
IL38441A0 (en) 1972-02-29
CS167961B2 (en) 1976-05-28
AR193370A1 (en) 1973-04-23
GB1374751A (en) 1974-11-20
NL7117893A (en) 1972-06-30
IE35920B1 (en) 1976-06-23
JPS5734996B1 (en) 1982-07-26
DE2064092A1 (en) 1972-07-20
SE398357B (en) 1977-12-19
ES398358A1 (en) 1974-09-01
ZA718677B (en) 1972-09-27
FI49774B (en) 1975-06-30
DE2064092C2 (en) 1983-06-01
BE777387A (en) 1972-06-28
NL175199C (en) 1984-10-01
NO135873C (en) 1977-06-15
FI49774C (en) 1975-10-10
JPS6234396B2 (en) 1987-07-27
BG26002A4 (en) 1979-01-12
JPS57150396A (en) 1982-09-17
NO135873B (en) 1977-03-07
DD99395A5 (en) 1973-08-05
BG25654A3 (en) 1978-11-10
PL82900B1 (en) 1975-10-31
ATA1111571A (en) 1975-09-15
FR2120073B1 (en) 1975-12-26
US3876766A (en) 1975-04-08
RO63065A (en) 1979-02-15
CH594051A5 (en) 1977-12-30
FR2120073A1 (en) 1972-08-11
RO63064A (en) 1978-06-15
DK139533C (en) 1979-08-20
CA979833A (en) 1975-12-16
IL38441A (en) 1974-10-22
IE35920L (en) 1972-06-28
KR780000248B1 (en) 1978-07-06
DK139533B (en) 1979-03-05
JPS6216638B2 (en) 1987-04-14
BG26003A4 (en) 1979-01-12

Similar Documents

Publication Publication Date Title
AT330122B (en) PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS
AT319235B (en) Process for the production of new 8-Azapurin-6-one derivatives
AT311557B (en) Process for the production of new α-aminopenicillins
AT339901B (en) PROCESS FOR PRODUCING NEW TETRAZOLE DERIVATIVES
AT297024B (en) Process for the production of the new di-adenine-pyridoxal-phosphate
AT326138B (en) PROCESS FOR THE PRODUCTION OF NEW AZETIDINE-2-ON DERIVATIVES
AT303270B (en) Process for the production of new glucosides
AT330760B (en) PROCESS FOR PRODUCING NEW DERIVATIVES OF 2-AMINO-INDANE
AT327211B (en) PROCESS FOR THE PRODUCTION OF NEW AZETIDE DERIVATIVES
AT328461B (en) PROCESS FOR THE PRODUCTION OF NEW AZETIDE DERIVATIVES
AT323902B (en) PROCESS FOR THE PRODUCTION OF NEW THIO-PYRIMIDINE DERIVATIVES
AT310148B (en) Process for the production of new norpinan derivatives
AT309075B (en) Process for the production of new cyclocopolymers
AT312166B (en) PROCESS FOR THE PRODUCTION OF NEW ALKALINE POLYMETAPHOSPHATE COMPLEXES OF ALPHA-6-DESOXY-5-HYDROXYTE TRACYCLINE
AT330126B (en) PROCESS FOR PRODUCING NEW INHIBITORS FOR DIGESTIVE GLYCOSIDE HYDROLASIS
CH536358A (en) Process for the production of the new antibiotic largomycin
CH515327A (en) Process for the production of the new antibiotic thiopeptin
AT309705B (en) Process for the production of new 21-fluorosteroids
AT310958B (en) Process for the production of new octadecapeptides
AT300834B (en) Process for the production of new cyclophosphates
AT307395B (en) Process for the production of the new 7-formylacenaphthene
AT321902B (en) PROCESS FOR PREPARING NEW NAPHTHOCHINONE DERIVATIVES
AT303256B (en) Process for the production of the new antibiotic axenomycin D
AT323340B (en) PROCESS FOR PRODUCING NEW OSTRATRIENS
AT308985B (en) Process for the production of new 16α18-dimethylpregnenes

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee